UltraGuide launches biopsy tool

Article

Medical device firm UltraGuide this month brought its UltraGuide 1000 ultrasound-guided interventional procedure tool to market. The Israeli firm developed the device for biopsies and treatments of abdominal organs and breast interventions, as well as

Medical device firm UltraGuide this month brought its UltraGuide 1000 ultrasound-guided interventional procedure tool to market. The Israeli firm developed the device for biopsies and treatments of abdominal organs and breast interventions, as well as cardiology, ob/gyn, and prenatal procedures. The device was cleared by the Food and Drug Administration in February of last year and is priced at about $45,000 (SCAN 6/24/98).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.